Why ProKidney Corp.’s (PROK) Stock Is Down 6.52%
As of Friday, November 13, ProKidney Corp.’s PROK share price has dipped by 6.52%, which has investors questioning if this is right time to buy.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Tudor Pop
Jenna Brashear
Michael Rose
Rosalio Madrigal
| Share Statistics | PROK | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $217.0 | $202.9 | 30% |
|
| Shares Out (Mil) | 207.8 | 55.4 | 76% |
|
| Institutional Ownership | 96.9% | 92.9% | 71% |
|
| Float (Mil) | 185.2 | 40.7 | 72% |
|
| Beta | 1.89 | 1.04 | 90% |
|
| Avg Daily Volume (000s) | 1,179 | 566 | 71% |
|
| Price Change (52-week) |
(54.6%) | 41.0% | 18% |
|
| Growth | PROK | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.2% | na |
|
| Net Income (5yr) | (20.9%) | (10.3%) | 19% |
|
| EPS (5yr) | (15.1%) | 15.8% | 18 |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | 22.0% | (15.7%) | 81% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 4 | |
| Current EPS | ($0.180) | ($0.649) | ($0.626) | |
| Month Ago EPS | ($0.138) | ($0.562) | ($0.586) | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 1 | 0 | 0 | |
| Three Months Ago EPS | ($0.138) | ($0.562) | ($0.586) | |
| Year/Year Chg | 5.3% | 26.0% | (2.9%) | |
| Financials | PROK | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1 | $39 | 2% |
|
| Net Income (TTM) (Mil) | ($103) | ($44) | 11% |
|
| EPS (TTM) | ($0.609) | ($1.400) | 25% |
|
| Operating Cash Flow (TTM) (Mil) | ($153) | ($34) | 5% |
|
| Net Cash Flow (TTM) (Mil) | ($14) | ($1) | 30% |
|
| Long-Term Debt (Q1) (Mil) | $2 | $4 | 20% |
|
| Enterprise Value (Q1) (Mil) | $1,164 | $144 | 43% |
|
| Valuation | PROK | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.97 | na |
|
| P/E | na | 17.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.8 | na |
|
| Ratios | PROK | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 67.6% | 96% |
|
| Net Margin | na | (50.6%) | na |
|
| ROA | (36.8%) | (47.4%) | 14% |
|
| ROE | 10.8% | (53.5%) | 59% |
|
| Liabilities to Assets | 15.8% | 29.7% | 10% |
|
| F-Score | 4 | 3 | 33% |
|
ProKidney Corp. did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors